Koninklijke Philips (PHG) Cash from Investing Activities (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.59% |
| Dec 31, 2025 | -35.65% |
| Sep 30, 2025 | -46.26% |
| Jun 30, 2025 | -161.83% |
| Mar 31, 2025 | 73.03% |
| Dec 31, 2024 | -17.63% |
| Sep 30, 2024 | -196.56% |
| Jun 30, 2024 | 7.67% |
| Mar 31, 2024 | 72.22% |
| Dec 31, 2017 | -46.70% |
| Sep 30, 2017 | -521.03% |
| Dec 31, 2016 | -490.13% |
| Sep 30, 2016 | 64.20% |
| Jun 30, 2016 | -78.18% |
| Mar 31, 2016 | 85.28% |
| Dec 31, 2015 | -10.89% |
| Sep 30, 2015 | -15.21% |
| Jun 30, 2015 | -16.07% |
| Mar 31, 2015 | -16.67% |
| Jun 30, 2013 | -53.91% |
| Mar 31, 2013 | 68.74% |
| Dec 31, 2012 | -57.51% |
| Sep 30, 2012 | -76.93% |
| Jun 30, 2012 | -121.80% |
| Mar 31, 2012 | 88.86% |
| Dec 31, 2011 | -46.82% |
| Sep 30, 2011 | -58.06% |
| Jun 30, 2011 | -206.76% |
| Mar 31, 2011 | 34.45% |
| Dec 31, 2010 | -435.56% |
| Sep 30, 2010 | 82.75% |
| Jun 30, 2010 | -247.44% |
| Mar 31, 2010 | 64.03% |